Dupont De Nemours Inc reports results for the quarter ended June 30 - Earnings Summary
Dupont De Nemours Inc reports results for the quarter ended June 30 - Earnings Summary
Dupont De Nemours Inc DD.N reported quarterly adjusted earnings of $1.88 per share for the quarter ended June 30, lower than the same quarter last year, when the company reported EPS of $3.36. The mean expectation of fifteen analysts for the quarter was for earnings of $1.76 per share. Wall Street expected results to range from $1.73 to $1.78 per share.
Revenue fell 44.2% to $1.82 billion from a year ago; analysts expected $1.81 billion.
Dupont De Nemours Inc's reported EPS for the quarter was $1.37.
The company reported quarterly net income of $187 million.
Dupont De Nemours Inc shares had risen by 4.2% this quarter and gained 17.1% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had fallen by about 1.5% in the last three months.
In the last 30 days, four analysts negatively revised earnings estimates
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 15 "strong buy" or "buy," 3 "hold" and no "sell" or "strong sell." The average consensus recommendation for the specialty chemicals peer group is also "buy"
Wall Street's median 12-month price target for Dupont De Nemours Inc is $164.50, about 14.1% above its last closing price of $141.28
This summary was machine generated from LSEG data August 4 at 11:03 a.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Jun. 30 2026 | 1.76 | 1.88 | Beat |
Mar. 31 2026 | 1.45 | 1.65 | Beat |
Dec. 31 2025 | 1.29 | 1.38 | Beat |
Sep. 30 2025 | 3.18 | 3.27 | Beat |
Recent news on DuPont de Nemours
See all newsUS RESEARCH ROUNDUP-BlackRock, Microsoft, TransDigm Group
Brief: Dupont Announces Regular Quarterly Dividend On Common Stock
US RESEARCH ROUNDUP-3M, C4 Therapeutics, PepsiCo
3M, DuPont must face Connecticut firefighters' lawsuit over 'forever chemicals'
Chemours, DuPont, Corteva settle North Carolina 'forever chemicals' claims for $455 million